Increased financial incentives and international collaborations required to tackle superbugs, says GlobalData

摘要

Increased international collaboration and further financial incentives are required to fight the mounting threat posed by multidrug-resistant bacteria, says consultancy firm GlobalData. According to Mirco Junker, Global Data's analyst covering infectious diseases, the current economic framework has stifled innovative R&D in this field, and has led to major pharma companies retreating from developing new antimicrobials.